Article info
PDFClinical and epidemiological research
Extended report
Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis
- Correspondence to Dr Adeline Ruyssen-Witrand, Centre de Rhumatologie, Hôpital Purpan, CHU Toulouse, Toulouse 31059, France; ruyssen-witrand.a{at}chu-toulouse.fr
Citation
Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis
Publication history
- Received September 21, 2017
- Revised November 16, 2017
- Accepted November 17, 2017
- First published November 29, 2017.
Online issue publication
October 31, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.